Literature DB >> 3462748

Proenkephalin is processed in a projection-specific manner in the rat central nervous system.

J D White, C M Gall, J F McKelvy.   

Abstract

The biosynthesis and posttranslational proteolytic processing of proenkephalin was studied in three projection systems in the rat central nervous system--the caudate-putamen to the globus pallidus, the paraventricular nucleus of the hypothalamus to the median eminence, and the mossy fiber system of the granule cells of the hippocampus. By using the techniques of in vivo radiolabeling and sequential high-performance liquid chromatographic purification coupled with chemical modification, the biosynthesis of six radiolabeled [Met]enkephalin-containing peptides--[Met5]enkephalin, [Met5,Arg6,Gly7,Leu8]enkephalin, [Met5,Arg6,Phe7]enkephalin, metorphamide, peptide E, and BAM 18P--was followed. In each projection system, radiolabeled enkephalins were purified to constant radiochemical specific activity. However, the posttranslational processing of proenkephalin was found to differ between these three systems, as judged by the relative ratio of these peptides. These findings imply that specific, different physiologies and behaviors may be elicited by the enkephalins based upon the specific [Met]enkephalin-containing peptides that are cleaved from proenkephalin and released in synaptic terminal fields.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3462748      PMCID: PMC386660          DOI: 10.1073/pnas.83.18.7099

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions.

Authors:  E Weber; C J Evans; J D Barchas
Journal:  Nature       Date:  1982-09-02       Impact factor: 49.962

2.  Novel C-terminally amidated opioid peptide in human phaeochromocytoma tumour.

Authors:  H Matsuo; A Miyata; K Mizuno
Journal:  Nature       Date:  1983 Oct 20-26       Impact factor: 49.962

Review 3.  Classification of opioid receptors.

Authors:  S J Paterson; L E Robson; H W Kosterlitz
Journal:  Br Med Bull       Date:  1983-01       Impact factor: 4.291

4.  Presence in brain of synenkephalin, a proenkephalin-immunoreactive protein which does not contain enkephalin.

Authors:  D R Liston; J J Vanderhaeghen; J Rossier
Journal:  Nature       Date:  1983-03-03       Impact factor: 49.962

5.  Opioid peptides derived from pro-enkephalin A but not that from pro-enkephalin B are substantial analgesics after administration into brain of mice.

Authors:  V Höllt; F C Tulunay; S K Woo; H H Loh; A Herz
Journal:  Eur J Pharmacol       Date:  1982-12-03       Impact factor: 4.432

6.  The PHI (PHI-27)/corticotropin-releasing factor/enkephalin immunoreactive hypothalamic neuron: possible morphological basis for integrated control of prolactin, corticotropin, and growth hormone secretion.

Authors:  T Hökfelt; J Fahrenkrug; K Tatemoto; V Mutt; S Werner; A L Hulting; L Terenius; K J Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

7.  Purification and characterization of enkephalin convertase, an enkephalin-synthesizing carboxypeptidase.

Authors:  L D Fricker; S H Snyder
Journal:  J Biol Chem       Date:  1983-09-25       Impact factor: 5.157

8.  Measurement of methionine-enkephalin [Arg6,Phe7] in rat brain by specific radioimmunoassay directed at methionine sulphoxide enkephalin[Arg6,Phe7].

Authors:  M R Boarder; A J Lockfeld; J D Barchas
Journal:  J Neurochem       Date:  1982-02       Impact factor: 5.372

9.  Distribution of enkephalin-related peptides in rat brain: immunohistochemical studies using antisera to met-enkephalin and met-enkephalin Arg6Phe7.

Authors:  R G Williams; G J Dockray
Journal:  Neuroscience       Date:  1983-07       Impact factor: 3.590

10.  Metorphamide: isolation, structure, and biologic activity of an amidated opioid octapeptide from bovine brain.

Authors:  E Weber; F S Esch; P Böhlen; S Paterson; A D Corbett; A T McKnight; H W Kosterlitz; J D Barchas; C J Evans
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.